Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe
Hari K. Rachamala(Jacksonville College), Krishnendu Pal(Jacksonville College), Debabrata Mukhopadhyay(Jacksonville College), Naga Malleswara Rao Nakka(Jacksonville College), Vijay Sagar Madamsetty(Jacksonville College), Shamit K. Dutta(WinnMed), Enfeng Wang(Jacksonville College), Ramcharan Singh Angom(Mayo Clinic in Arizona)
Cited by 20
Related Papers
In vivo gene delivery mediated by non-viral vectors for cancer therapy
|Journal of Controlled Release|2020|240
Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics
|Frontiers in Pharmacology|2019|210
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
|ACS Biomaterials Science & Engineering|2022|174
Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
|Advanced Functional Materials|2020|153
Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer
|International Journal of Molecular Sciences|2020|103